Oct 3, 2025
American patients have shouldered a disproportionate share of the globe's research and development tab.
Sep 25, 2025
Unless our own government changes course, we'll suffer the same fate as Britain. Signs of drug companies losing patience with Britain's price controls have been apparent for years. The British government has ensured that drug firms have fewer resources for medicines.
Sep 16, 2025
Eliminating regulations that make it difficult to build factories and gain regulatory approval for new drug-manufacturing facilities would be far more effective at convincing pharmaceutical companies to set up shop here.
Sep 4, 2025
The Biden administration made exchange premium subsidies even more generous than the Affordable Care Act. The 2022 Inflation Reduction Act extended those enhanced subsidies. Anyone earning between 100% and 150% of the federal poverty level has access to zero-cost insurance.
Aug 29, 2025
The choice before the Trump administration is whether to move forward with drug price controls that will sap the pharmaceutical sector of resources, energy, and ingenuity -- or whether it will work to build a freer market for prescription drugs.
Aug 21, 2025
Reports of overdoses, hospitalizations, and deaths tied to compounded drugs are mounting. Yet these unregulated copies of patented medicines, often churned out in makeshift facilities or unlicensed pharmacies, continued to be falsely marketed as safe, personalized alternatives.
Aug 14, 2025
The One Big Beautiful Bill Act (OBBBA) allows patients to use money from tax-advantaged health savings accounts to pay for direct primary care for the first time.
Aug 6, 2025
Drug tariffs of any kind are bad policy. They are nothing more than a tax increase on every American who relies on medicine to manage or recover from disease. And they'll make prescription drugs even less affordable.